Clinical trial

Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar…

NCT00211250 · Joliet Center for Clinical Research, Other · Completed

Key facts

NCT number NCT00211250
Title Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tients From Valproic Acid to Depakote ER
Official title An Exploratory Study Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar I and II Patients From Valproic Acid to Depakote ER
Lead sponsor Joliet Center for Clinical Research, Other
Collaborators Abbott Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Mood Disorder
Intervention type Drug
Interventions Valproic Acid and Depakote ER
Enrollment 20
Start date Jul 1, 2005
Primary completion Jul 1, 2006
Completion Sep 1, 2006
First posted Sep 21, 2005
Last update posted Jan 28, 2009
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies